Reginato’s group first demonstrated negative regulation of MMP2 expression upon OGT inhibition using OGT shRNA in breast cancer cells (an effect probably mediated by down-regulation of FOXM1 protein), associated with decreased cell invasiveness (112). This evidence concerns the gene FOXM1 and breast cancer.